Dana Gerber can be reached at [email protected]
If you are losing weight steadily at your current dose, there may be no benefit to increasing
"HIV Transmission Risk through Anal Intercourse: Systematic Review, Meta-Analysis and Implications for HIV Prevention." Int J Epidemiol 39.4 (2010):1048-63
First, healthy-user bias is a major concern: individuals prescribed newer, more expensive agents such as semaglutide may systematically differ from comparator groups in terms of health behaviors, dietary patterns, physical activity, adherence to medical care, and access to healthcare resources
Semaglutide is a medication initially approved for the treatment of type 2 diabetes
To assess the importance of lipidation modification to Cagri, pharmacological comparison of Cagri and its non-lipidated backbone (CagriBB) was undertaken using a cAMP response element (CRE)-reporter assay